Chemoinformaics analysis of Phthalic acid di-(ptolyl)ester
| Molecular Weight | 346.382 | nRot | 4 |
| Heavy Atom Molecular Weight | 328.238 | nRig | 20 |
| Exact Molecular Weight | 346.121 | nRing | 3 |
| Solubility: LogS | -6.498 | nHRing | 0 |
| Solubility: LogP | 5.089 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 3 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 18 |
| nHA | 4 | APOL | 51.9503 |
| nHD | 0 | BPOL | 23.2657 |
| QED | 0.506 |
| Synth | 1.692 |
| Natural Product Likeliness | -0.418 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.984 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.993 |
| MDCK | 0.000029 |
| BBB | 0.092 |
| PPB | 1.02303 |
| VDSS | 0.42 |
| FU | 0.00810194 |
| CYP1A2-inh | 0.375 |
| CYP1A2-sub | 0.196 |
| CYP2c19-inh | 0.79 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.556 |
| CYP2c9-sub | 0.916 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.623 |
| CYP3a4-inh | 0.165 |
| CYP3a4-sub | 0.176 |
| CL | 8.205 |
| T12 | 0.154 |
| hERG | 0.144 |
| Ames | 0.029 |
| ROA | 0.015 |
| SkinSen | 0.955 |
| Carcinogencity | 0.697 |
| EI | 0.979 |
| Respiratory | 0.186 |
| NR-Aromatase | 0.022 |
| Antiviral | Yes |
| Prediction | 0.768251 |